We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Hearts at Rest May Recover from Heart Failure

By HospiMedica International staff writers
Posted on 18 Apr 2012
Structural changes in heart muscle cells following heart failure (HF) are not permanent, and can be reversed by allowing the heart to rest, according to a new study.

Researchers at the Harefield Heart Science Centre (HHSC; London, United Kingdom) and Imperial College London (ICL; United Kingdom) induced HF in rats by left coronary artery ligation for 12 weeks; the failing hearts were then mechanically unloaded for 4 weeks by heterotopic abdominal heart transplantation (HF-UN), a microsurgical technique for vascular anastomosis, whereby the donor's thoracic aorta is connected end-to-side to the recipient's infrarenal abdominal aorta, and the donor's pulmonary artery is connected to the recipient's inferior vena cava. More...
The researchers aim was to reduce transverse (t)-tubule system disruption, which occurs early in HF.

The researchers found that HF-UN reversed the t-tubule density reduction observed by HF in isolated left ventricular myocytes. The deterioration in the regularity of the t-tubule system in HF was also reversed in HF-UN, as demonstrated by scanning ion conductance microscopy that showed the reappearance of normal surface striations, and electron microscopy that revealed recovery of normal t-tubule micro-architecture. According to the researchers, the process is similar to that of using a left ventricle assist device (LVAD) to boost heart function and reduce strain on the left ventricle, thus helping the heart muscle similarly recover. The study was published early online on April 2, 2012, in the European Journal of Heart Failure.

“This is the first demonstration that this important form of remodeling of heart muscle cells induced by heart failure is reversible,” said lead author Michael Ibrahim, PhD, of the HHSC laboratory of cell electrophysiology. “If we can discover the molecular mechanisms for these changes, it might be possible to induce recovery without a serious procedure like having an LVAD implanted.”

The transverse (t)-tubule system is a deep invagination of the sarcolemma found in skeletal and cardiac muscle cells. These invaginations allow depolarization of the membrane to quickly penetrate to the interior of the cell. The system guarantees the proximity of the triggers for Ca2+ induced Ca2+ release (CICR), a process whereby calcium can trigger release of further calcium from the muscle sarcoplasmic reticulum, which is critical for contraction in cardiomyocytes.

Related Links:

Harefield Heart Science Centre
Imperial College London



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.